BESTAGRO
Best Agrolife financials
- Market cap
- ₹803 Cr
- Sector
- Chemicals
- Calls analysed
- 7
Best Agrolife Limited Q1 FY27
What went well
- Revenue from operations increased 4% YoY to ₹396 crores, demonstrating resilient performance despite seasonal challenges.
- EBITDA grew significantly by 70% YoY to ₹78 crores, with EBITDA margin expanding to 20% from 12% in Q1 FY26, driven by product mix and operational efficiency.
- PAT more than doubled, growing 104% YoY to ₹41 crores, with PAT margin improving to 10% from 5% in Q1 FY26.
What to watch
- Delayed monsoons and irregular rainfall impacted demand and planting in Q1 FY27, leading to subdued top-line growth.
- Early predictions of 2026 and 2027 being a super El Niño year raise concerns about future monsoon impact and extreme weather.
What Best Agrolife Limited does
Best Agrolife Limited manufactures technical-grade active ingredients and formulated crop-protection products — insecticides, fungicides, herbicides, plant growth regulators and bio-fertilizers/bio-stimulants — for Indian agriculture. It sells through two channels: branded (patented, proprietary formulations marketed directly to farmers via its dealer network) and institutional (bulk technicals/formulations supplied to other companies). Manufacturing is carried out at its own ISO-certified plants, with R&D conducted at NABL-accredited laboratories, and products are also exported to international markets through subsidiaries such as Best Agrolife Global (Mauritius) and Best Agrolife (Shanghai) Co. Ltd.
Segments
- Branded (B2C) sales
- Institutional (B2B) sales
- Manufacturing units
- 4 (Gajraula & Greater Noida, Uttar Pradesh; Jammu, J&K)
- Technicals manufacturing capacity
- 7,000 MTPA
- Formulations manufacturing capacity
- 35,500 kL/annum
- Warehouses
- 40 (across 21 states)
- Dealer network
- 10,000+
- Key patented products
- 9
Guidance record · Q1 FY27
what the last two calls moved 19 tracked 2 delivered 8 missed 9 open- Q1 FY27 Performance delivered said Q4 FY26 Promised: Better numbers (top line and bottom line) Q1 FY27: Q1 FY27 results showed significant improvement: Revenue +4% YoY, EBITDA +70% YoY, and PAT +104% YoY.
- New Generation Molecules Production (FY27) went quiet said Q4 FY26 Promised: At least 4 new generation molecules will be produced this year at the Gajraula facility Q1 FY27: No specific update was provided on the production of 4 new generation molecules at the Gajraula facility.
- New Patented Products per year revised down said Q4 FY25 Promised: 3 to 4 patented products every year Q1 FY27: Management stated 'As of now, no new products for the current year', contradicting the previous quarter's guidance to launch 3-4 new patented products in FY27.
All 19 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 3.9%, net profit up 105.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 747 | 274 | 274 | 381 | 517 −31% | 203 −26% | 156 −43% | 396 +4% |
| EBITDA | 147 | -6 | 4 | 46 | 78 −47% | 4 +167% | -27 −775% | 78 +70% |
| Net profit | 95 | -24 | -22 | 20 | 39 −59% | -13 +46% | -37 −68% | 41 +105% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −95.0% 1Y
1Y: ₹384.2 on 10 Sept 2025 → ₹19.05. High ₹438 (7 Jan 2026), low ₹12.3 (30 Mar 2026).
How the price took the results
close before → close after
- Q1 FY27
- +20.0%
- 4 Aug
- Q4 FY26
- −8.9%
- 28 May
- Q3 FY26
- −5.0%
- 9 Feb
- Q2 FY26
- −2.9%
- 14 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue fell 10.4% a year over 3 years, FY23 to FY26. Operating margin narrowed to 8.0%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹1.7k Cr | ₹1.9k Cr | ₹1.8k Cr | ₹1.3k Cr |
| Operating profit | ₹314 Cr | ₹226 Cr | ₹200 Cr | ₹101 Cr |
| Operating margin | 18.0% | 12.1% | 11.0% | 8.0% |
| Interest | ₹39 Cr | ₹61 Cr | ₹65 Cr | ₹54 Cr |
| Depreciation | ₹25 Cr | ₹32 Cr | ₹43 Cr | ₹40 Cr |
| Net profit | ₹193 Cr | ₹106 Cr | ₹70 Cr | ₹9 Cr |
| Net margin | 11.1% | 5.7% | 3.9% | 0.7% |
| Cash from operations | ₹-180 Cr | ₹36 Cr | ₹228 Cr | ₹97 Cr |
| Free cash flow | ₹-218 Cr | ₹-10 Cr | ₹208 Cr | ₹91 Cr |
| ROCE | 34.0% | 16.0% | 13.0% | 5.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹22 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹35 Cr |
| Reserves | ₹108 Cr | ₹306 Cr | ₹504 Cr | ₹623 Cr | ₹786 Cr | ₹733 Cr |
| Borrowings | ₹33 Cr | ₹270 Cr | ₹568 Cr | ₹637 Cr | ₹436 Cr | ₹442 Cr |
| Other liabilities | ₹209 Cr | ₹384 Cr | ₹380 Cr | ₹729 Cr | ₹718 Cr | ₹475 Cr |
| Total liabilities | ₹372 Cr | ₹984 Cr | ₹1.5k Cr | ₹2.0k Cr | ₹2.0k Cr | ₹1.7k Cr |
| Fixed assets | ₹19 Cr | ₹180 Cr | ₹203 Cr | ₹362 Cr | ₹356 Cr | ₹351 Cr |
| Capital work in progress | ₹4 Cr | ₹5 Cr | ₹14 Cr | ₹15 Cr | ₹1 Cr | ₹1 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Other assets | ₹349 Cr | ₹800 Cr | ₹1.3k Cr | ₹1.6k Cr | ₹1.6k Cr | ₹1.3k Cr |
| Total assets | ₹372 Cr | ₹984 Cr | ₹1.5k Cr | ₹2.0k Cr | ₹2.0k Cr | ₹1.7k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
All earnings calls (7)
Read the Q1 FY27 call →Learn to analyse Best Agrolife Limited
Guides on how to read this kind of business and the numbers that matter.